Details
Stereochemistry | RACEMIC |
Molecular Formula | C18H22BrNO |
Molecular Weight | 348.277 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCOC(C)(C1=CC=CC=C1)C2=CC=C(Br)C=C2
InChI
InChIKey=URSRSKSNFPUKGH-UHFFFAOYSA-N
InChI=1S/C18H22BrNO/c1-18(21-14-13-20(2)3,15-7-5-4-6-8-15)16-9-11-17(19)12-10-16/h4-12H,13-14H2,1-3H3
Molecular Formula | C18H22BrNO |
Molecular Weight | 348.277 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL231 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7758143 |
PubMed
Title | Date | PubMed |
---|---|---|
Pharmacological intervention with platelet phospholipase A2. | 2001 |
|
Vitrification of mouse oocytes using a nylon loop. | 2001 Mar |
|
Cationic amphiphilic drugs and platelet phospholipase A(2) (cPLA(2)). | 2002 Feb 15 |
|
Titrimetric and spectrophotometric assay of some antihistamines through the determination of the chloride of their hydrochlorides. | 2002 Jan |
|
H(1)- antihistamines and activated blood platelets. | 2006 Apr |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:57:58 GMT 2023
by
admin
on
Sat Dec 16 17:57:58 GMT 2023
|
Record UNII |
HH0KD7Z416
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Sat Dec 16 17:57:58 GMT 2023 , Edited by admin on Sat Dec 16 17:57:58 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
998
Created by
admin on Sat Dec 16 17:57:58 GMT 2023 , Edited by admin on Sat Dec 16 17:57:58 GMT 2023
|
PRIMARY | |||
|
C81150
Created by
admin on Sat Dec 16 17:57:58 GMT 2023 , Edited by admin on Sat Dec 16 17:57:58 GMT 2023
|
PRIMARY | |||
|
SUB06500MIG
Created by
admin on Sat Dec 16 17:57:58 GMT 2023 , Edited by admin on Sat Dec 16 17:57:58 GMT 2023
|
PRIMARY | |||
|
DTXSID60863198
Created by
admin on Sat Dec 16 17:57:58 GMT 2023 , Edited by admin on Sat Dec 16 17:57:58 GMT 2023
|
PRIMARY | |||
|
1784
Created by
admin on Sat Dec 16 17:57:58 GMT 2023 , Edited by admin on Sat Dec 16 17:57:58 GMT 2023
|
PRIMARY | |||
|
C005715
Created by
admin on Sat Dec 16 17:57:58 GMT 2023 , Edited by admin on Sat Dec 16 17:57:58 GMT 2023
|
PRIMARY | |||
|
19105
Created by
admin on Sat Dec 16 17:57:58 GMT 2023 , Edited by admin on Sat Dec 16 17:57:58 GMT 2023
|
PRIMARY | |||
|
m1131
Created by
admin on Sat Dec 16 17:57:58 GMT 2023 , Edited by admin on Sat Dec 16 17:57:58 GMT 2023
|
PRIMARY | Merck Index | ||
|
3565-72-8
Created by
admin on Sat Dec 16 17:57:58 GMT 2023 , Edited by admin on Sat Dec 16 17:57:58 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110819
Created by
admin on Sat Dec 16 17:57:58 GMT 2023 , Edited by admin on Sat Dec 16 17:57:58 GMT 2023
|
PRIMARY | |||
|
100000080773
Created by
admin on Sat Dec 16 17:57:58 GMT 2023 , Edited by admin on Sat Dec 16 17:57:58 GMT 2023
|
PRIMARY | |||
|
HH0KD7Z416
Created by
admin on Sat Dec 16 17:57:58 GMT 2023 , Edited by admin on Sat Dec 16 17:57:58 GMT 2023
|
PRIMARY | |||
|
EMBRAMINE
Created by
admin on Sat Dec 16 17:57:58 GMT 2023 , Edited by admin on Sat Dec 16 17:57:58 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
ENANTIOMER -> RACEMATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
ENANTIOMER -> RACEMATE | |||
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |